Enanta Pharmaceuticals (ENTA) Insider Trading & Ownership $13.39 +0.25 (+1.90%) (As of 07/5/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.64%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$347,538.81 ENTA Insider Buying and Selling by Quarter Ad All American AssetsWhy Conservative Americans Are Turning to Gold in 2024Welcome to the financial rollercoaster of 2024, where inflation is relentless, stock markets are inflated, and global conflicts are escalating. Under Biden's disastrous policies, our savings are being devalued faster than ever. Protecting your wealth has never been more urgent. That's why we've created 3 Essential Guides to help you navigate these uncertain times and ensure your savings last as long as you do.Claim Your Kit Now Enanta Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/17/2024Tara Lynn KiefferInsiderSell7,266$12.33$89,589.78 12/13/2023Terry VanceDirectorSell15,295$9.12$139,490.40 12/5/2023Brendan LuuVPSell2,125$9.63$20,463.75 12/5/2023Jay R LulyCEOSell7,230$9.63$69,624.90 12/5/2023Paul J MellettCFOSell2,412$9.63$23,227.56 12/5/2023Scott T RottinghausCMOSell534$9.63$5,142.42 (Data available from 1/1/2013 forward) ENTA Insider Trading Activity - Frequently Asked Questions Who is on Enanta Pharmaceuticals's Insider Roster? The list of insiders at Enanta Pharmaceuticals includes Brendan Luu, Bruce L A Carter, Jay R Luly, Nathalie Adda, Paul J Mellett, Scott T Rottinghaus, Tara Lynn Kieffer, Terry Vance, and Yat Sun Or. Learn more on insiders at ENTA. What percentage of Enanta Pharmaceuticals stock is owned by insiders? 13.64% of Enanta Pharmaceuticals stock is owned by insiders. Learn more on ENTA's insider holdings. Which Enanta Pharmaceuticals insiders have been selling company stock? The following insiders have sold ENTA shares in the last 24 months: Brendan Luu ($20,463.75), Jay R Luly ($2,671,730.82), Paul J Mellett ($755,876.76), Scott T Rottinghaus ($5,142.42), Tara Lynn Kieffer ($89,589.78), Terry Vance ($139,490.40), and Yat Sun Or ($618,966.25). How much insider selling is happening at Enanta Pharmaceuticals? Insiders have sold a total of 122,139 Enanta Pharmaceuticals shares in the last 24 months for a total of $4,301,260.18 sold. Which members of congress are trading Enanta Pharmaceuticals? Daniel S. Goldman (D-NY) has sold shares of Enanta Pharmaceuticals in the last year totaling $8,000. More Insider Trading Tools from MarketBeat Related Companies: ARQT Insider Trading OCUL Insider Trading COLL Insider Trading NRIX Insider Trading INVA Insider Trading IRWD Insider Trading GYRE Insider Trading TNGX Insider Trading LQDA Insider Trading CNTA Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, TreaceIs CAVA Overextended? A Closer Look at This High-Flying StockOccidental Petroleum: Buffett Causes OXY Stock Rebound3 Tech Stocks Insiders, Major Shareholders, and Institutions BuyThe Top 3 Stocks Sold by Insiders This Quarter This page (NASDAQ:ENTA) was last updated on 7/6/2024 by MarketBeat.com Staff From Our PartnersWhy Conservative Americans Are Turning to Gold in 2024Welcome to the financial rollercoaster of 2024, where inflation is relentless, stock markets are inflated, and...All American Assets | Sponsored50-year Wall Street Legend Issues July Stock WarningJuly is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Weiss Ratings | SponsoredSilver Expected for Extreme Price ActionOur newest Silver Investing Guide reveals how savvy investors are capitalizing on silver's continued rise – PL...Colonial Metals | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthles...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Enanta Pharmaceuticals, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Enanta Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
